发明名称 KIDNEY CELL CARCINOMA
摘要 The process for the diagnosis of a renal cell carcinoma comprises the step of determining the presence or absence or amplitude of at least three polypeptide markers in a urine sample, wherein said polypeptide markers are selected from the markers as characterized in Table 1 by molecular masses and migration times.
申请公布号 US2015024970(A1) 申请公布日期 2015.01.22
申请号 US201414503617 申请日期 2014.10.01
申请人 Mosaiques Diagnostics and Therapeutics AG 发明人 Mischak Harald
分类号 G01N33/574;G01N33/493 主分类号 G01N33/574
代理机构 代理人
主权项 1. A process for the diagnosis of a renal cell carcinoma, comprising: measuring the presence or absence based on occurrence frequency measurements or concentration amplitude altered in a disease state of at least three polypeptide markers in a urine sample, wherein said polypeptide markers are selected from the markers as identified in Table 1; and comparing the presence or absence or amplitudes with corresponding values of a healthy population of patients, and with corresponding values of a population of patients with renal cell carcinoma to obtain the diagnosis.
地址 Hannover DE